• Oxford BioMedica plc, of Oxford, UK, disclosed details of a proposed share issue to raise gross proceeds of £16 million (US$24.8 million) – £14.5 million net of expenses – by way of placing 440 million new ordinary shares priced at 1 pence apiece and an open offer of up to 201 million shares priced at 2.5 apiece.